Rational Design of Highly Potent and Slow-Binding Cytochrome bc1 Inhibitor as Fungicide by Computational Substitution Optimization

Hit to lead (H2L) optimization is a key step for drug and agrochemical discovery. A critical challenge for H2L optimization is the low efficiency due to the lack of predictive method with high accuracy. We described a new computational method called Computational Substitution Optimization (CSO) that has allowed us to rapidly identify compounds with cytochrome bc1 complex inhibitory activity in the nanomolar and subnanomolar range. The comprehensively optimized candidate has proved to be a slow binding inhibitor of bc1 complex, ~73-fold more potent (Ki = 4.1 nM) than the best commercial fungicide azoxystrobin (AZ; Ki = 297.6 nM) and shows excellent in vivo fungicidal activity against downy mildew and powdery mildew disease. The excellent correlation between experimental and calculated binding free-energy shifts together with further crystallographic analysis confirmed the prediction accuracy of CSO method. To the best of our knowledge, CSO is a new computational approach to substitution-scanning mutagenesis of ligand and could be used as a general strategy of H2L optimisation in drug and agrochemical design.

[1]  John Delaney,et al.  Modern agrochemical research: a missed opportunity for drug discovery? , 2006, Drug discovery today.

[2]  Nathan Brown,et al.  Fragment-based hit identification: thinking in 3D. , 2013, Drug discovery today.

[3]  V. Barton,et al.  Inhibiting Plasmodium cytochrome bc1: a complex issue. , 2010, Current opinion in chemical biology.

[4]  Dana Goodman Thinking in 3D , 2006 .

[5]  Robert V. Swift,et al.  Rational Prediction with Molecular Dynamics for Hit Identification , 2012, Current topics in medicinal chemistry.

[6]  Zhengming Li,et al.  Synthesis and biological activity of some novel trifluoromethyl-substituted 1,2,4-triazole and bis(1,2,4-triazole) Mannich bases containing piperazine rings. , 2010, Journal of agricultural and food chemistry.

[7]  A. Hopkins,et al.  Ligand efficiency: a useful metric for lead selection. , 2004, Drug discovery today.

[8]  M. Shaw,et al.  Sensitivity distributions and cross-resistance patterns of Mycosphaerella graminicola to fluquinconazole, prochloraz and azoxystrobin over a period of 9 years , 2005 .

[9]  Jayaraman Chandrasekhar,et al.  Strategies and tactics for optimizing the Hit-to-Lead process and beyond--a computational chemistry perspective. , 2008, Drug discovery today.

[10]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[11]  A. Hudson,et al.  Atovaquone - a novel broad-spectrum anti-infective drug. , 1993, Parasitology today.

[12]  A. Caflisch,et al.  Molecular dynamics in drug design. , 2015, European journal of medicinal chemistry.

[13]  Steven E. Wheeler,et al.  Substituent effects in the benzene dimer are due to direct interactions of the substituents with the unsubstituted benzene. , 2008, Journal of the American Chemical Society.

[14]  Andrew Plant,et al.  Current Challenges and Trends in the Discovery of Agrochemicals , 2013, Science.

[15]  C. Zhan,et al.  Subnanomolar inhibitor of cytochrome bc1 complex designed by optimizing interaction with conformationally flexible residues. , 2010, Journal of the American Chemical Society.

[16]  Rommie E. Amaro,et al.  AutoGrow: A Novel Algorithm for Protein Inhibitor Design , 2009, Chemical biology & drug design.

[17]  Michael Lanzer,et al.  Drug‐resistant malaria: Molecular mechanisms and implications for public health , 2011, FEBS letters.

[18]  B. Meunier,et al.  Modeling the Qo site of crop pathogens in Saccharomyces cerevisiae cytochrome b. , 2004, European journal of biochemistry.

[19]  M. A. Spies,et al.  In silico Optimization of a Fragment‐Based Hit Yields Biologically Active, High‐Efficiency Inhibitors for Glutamate Racemase , 2013, ChemMedChem.

[20]  Ge-Fei Hao,et al.  Computational discovery of picomolar Q(o) site inhibitors of cytochrome bc1 complex. , 2012, Journal of the American Chemical Society.

[21]  J. Topliss,et al.  Chance factors in studies of quantitative structure-activity relationships. , 1979, Journal of medicinal chemistry.

[22]  David M Kramer,et al.  A semiquinone intermediate generated at the Qo site of the cytochrome bc1 complex: Importance for the Q-cycle and superoxide production , 2007, Proceedings of the National Academy of Sciences.

[23]  J. Todd,et al.  A complex issue. , 1995, Trends in Genetics.

[24]  Guangfu Yang,et al.  A Comparative Study on the Constitutive Properties of Marketed Pesticides , 2011, Molecular informatics.

[25]  D Horvath,et al.  From hit to lead. Analyzing structure-profile relationships. , 2001, Journal of medicinal chemistry.

[26]  Alexander Hillisch,et al.  Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits. , 2006, Drug discovery today.

[27]  T. Taylor,et al.  A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria , 2012, PloS one.

[28]  L. Yu,et al.  Quantitative resolution of succinate-cytochrome c reductase into succinate-ubiquinone and ubiquinol-cytochrome c reductases. , 1982, The Journal of biological chemistry.

[29]  Wei-Chun Kao,et al.  Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action , 2014, Nature Communications.

[30]  Michael F. Rafferty Hit to lead , 2013 .

[31]  U. Gisi,et al.  The Challenges of Chemical Control of Plant Diseases , 2010 .

[32]  György M Keseru,et al.  Hit discovery and hit-to-lead approaches. , 2006, Drug discovery today.

[33]  Aiying Guan,et al.  Application of the intermediate derivatization approach in agrochemical discovery. , 2014, Chemical reviews.